名古屋市立大学大学院医学研究科臨床病態病理学（病理学Ⅱ）のホームページです。

２０１７年

Miyake M, Ito Y, Suzuki H, Tomizawa M, Sato H, Liu M, Okamura A, Nakajima T,Ohtani K, Takino H, Inagaki H, Kamijima M. Epididymal phospholipidosis is apossible mechanism for spermatotoxicity induced by the organophosphorusinsecticide fenitrothion in rats. Toxicol Lett. 2018 Mar 15;285:27-33. doi:10.1016/j.toxlet.2017.12.023. Epub 2017 Dec 30. PubMed PMID: 29292090.

Aoyama S, Masaki A, Sakamoto Y, Takino H, Murase T, Ohshima K, Yoshino T, Kato S, Inagaki H. Achromobacter Infection Is Rare in Japanese Patients with Pulmonary B-cell Lymphoma. Intern Med. 2018 Mar 15;57(6):789-794. doi:10.2169/internalmedicine.9430-17. Epub 2017 Nov 20. PubMed PMID: 29151525; PubMed Central PMCID: PMC5891515.

Masaki A, Ishida T, Maeda Y, Ito A, Suzuki S, Narita T, Kinoshita S, Takino H, Yoshida T, Ri M, Kusumoto S, Komatsu H, Inagaki H, Ueda R, Choi I, Suehiro Y, Iida S. Clinical significance of tryptophan catabolism in Hodgkin lymphoma. Cancer Sci. 2018 Jan;109(1):74-83. doi: 10.1111/cas.13432. Epub 2017 Nov 29. PubMed PMID: 29080383; PubMed Central PMCID: PMC5765298.

Narita T, Ishida T, Ito A, Masaki A, Kinoshita S, Suzuki S, Takino H, Yoshida T, Ri M, Kusumoto S, Komatsu H, Imada K, Tanaka Y, Takaori-Kondo A, Inagaki H, Scholz A, Lienau P, Kuroda T, Ueda R, Iida S.
Cyclin-dependent kinase 9 is a novel specific molecular target in adult T-cell leukemia/lymphoma.
Blood. 2017 Aug 31;130(9):1114-1124.
doi: 10.1182/blood-2016-09-741983. Epub 2017 Jun 23. PubMed PMID: 28646117.

Sakamoto Y, Masaki A, Aoyama S, Han S, Saida K, Fujii K, Takino H, Murase T, Iida S, Inagaki H.
Improved clonality detection in B-cell lymphoma using a semi-nested modification of the BIOMED-2 PCR assay for IGH rearrangement: A paraffin-embedded tissue study.
Pathol Int. 2017 Sep;67(9):453-460.
doi: 10.1111/pin.12566. PubMed PMID: 28868745.

Fujii K, Murase T, Beppu S, Saida K, Takino H, Masaki A, Ijichi K, Kusafuka K, Iida Y, Onitsuka T, Yatabe Y, Hanai N, Hasegawa Y, Inagaki H.
MYB, MYBL1, MYBL2 and NFIB gene alterations and MYC overexpression in salivary gland adenoid cystic carcinoma.
Histopathology. 2017 Jun 8.
doi: 10.1111/his.13281. [Epub ahead of print] PubMed PMID: 28594149.

Ito Y, Fujii K, Murase T, Saida K, Okumura Y, Takino H, Masaki A, Beppu S, Kawakita D, Ijichi K, Inagaki H.
Striated duct adenoma presenting with intra-tumoral hematoma and papillary thyroid carcinoma-like histology.
Pathol Int. 2017 Jun;67(6):316-321.
doi: 10.1111/pin.12534. Epub 2017 Apr 25. PubMed PMID: 28440555.

Beppu S, Ito Y, Fujii K, Saida K, Takino H, Masaki A, Murase T, Kusafuka K, Iida Y, Onitsuka T, Yatabe Y, Hanai N, Hasegawa Y, Ijichi K, Murakami S, Inagaki H.
Expression of cancer/testis antigens in salivary gland carcinomas with reference to MAGE-A and NY-ESO-1 expression in adenoid cystic carcinoma.
Histopathology. 2017 Aug;71(2):305-315.
doi: 10.1111/his.13226. Epub 2017 Jun 2. PubMed PMID: 28370175.

Kusafuka K, Kawasaki T, Maeda M, Yamanegi K, Baba S, Ito Y, Inagaki H, Nakajima T.
Salivary duct carcinoma with rhabdoid features: a salivary counterpart of pleomorphic lobular carcinoma of the breast.
Histopathology. 2017 Jan;70(2):164-173.
doi: 10.1111/his.12987. Epub 2016 Jun 8. PubMed PMID: 27079821.

Aoyama S, Masaki A, Sakamoto Y, Takino H, Murase T, Ohshima K, Yoshino T, Kato S, Inagaki H. Achromobacter infection is rare in Japanese patients with pulmonary B-cell lymphoma
Internal Medicine In press.

Okumura Y, Murase T, Saida K, Fujii K, Takino H, Masaki A, Ijichi K, Shimozato K, Tada Y, Nibu K, Inagaki H. Post-operative Radiotherapy for T1/2N0M0 Mucoepidermoid Carcinoma Positive for CRTC1/3-MAML2 Fusions. Head and Neck, in press.

Inagaki H, Bell D, Brandwein-Gensler M.
Mucoepidermoid carcinoma (Chapter 4).
WHO Classification of Head and Neck Tumours. 4th ed. Ed.
El-Naggar AK, Chan JKC, Grandis JR, Takara T, Slootweg PJ.
WHO Press Lyon 2017 pp127.

Brandwein-Gensler M Bell D, Inagaki H, Katabi N, Leibo I, Seethala R, Triantafyllou A.
Mucoepidermoid carcinoma (Chapter 7).
WHO Classification of Head and Neck Tumours. 4th ed. Ed. El-Naggar AK, Chan JKC, Grandis JR, Takara T, Slootweg PJ. WHO Press Lyon 2017 pp163.

Wenig BM, Bell D, Chiosea S, Inagaki H, Seethala R.
Clear cell carcinoma (Chapter 4).
WHO Classification of Head and Neck Tumours. 4th ed. Ed.
El-Naggar AK, Chan JKC, Grandis JR, Takara T, Slootweg PJ.
WHO Press Lyon 2017 pp168.

Skalova A, Bell D, Bishop JA, Inagaki H, Seethala R, Vielh P. Secretory carcinoma (Chapter 4).
WHO Classification of Head and Neck Tumours. 4th ed. Ed.
El-Naggar AK, Chan JKC, Grandis JR, Takara T, Slootweg PJ.
WHO Press Lyon 2017 pp177.

稲垣宏、正木彩子
びまん性大細胞型B細胞リンパ腫および原発性縦隔大細胞型B細胞性リンパ腫の免疫表現型
特集/免疫表現型に基づいたリンパ系腫瘍の理解
血液内科　2017；74(6):765-770

稲垣宏　齋田昂佑. 腫瘍の検査：染色体・遺伝子転座―唾液腺がんを中心に.耳鼻咽喉科・頭頸部外科. 耳鼻咽喉科検査マニュアル　2017；89：291-299

２０１６年

Fujii K, Ishibashi K, Kato J, Kan J, Fujii K, Ito Y, Takino H, Masaki A, Murase T, Inagaki H. Cellular Level Characterization of B-cells Infiltrating Pulmonary MALT Lymphoma Tissues Virchows Archiv 2016;469:575-580. PMID:27600807

Kato J, Masaki A, Fujii K, Takino H, Murase T, Yonekura K, Utsunomiya A, Ishida T, Iida S, Inagaki H.
Quantitative PCR for HTLV-1 Provirus in Adult T-cell Leukemia/Lymphoma Using Paraffin Tumor Sections Pathol Int 2016;66:618-621. PMID:27678343

Shinomiya H, Ito Y, Kubo M, Yonezawa K, Otsuki N, Iwae S, Inagaki H, Nibu K.
Expression of Amphiregulin in Mucoepidermoid Carcinoma of the Major Salivary Glands: A Molecular and Clinicopathological Study.
Hum Pathol 2016;57:37-44. PMID:27393417

Suzuki T, Kusumoto S, Yamashita T, Masuda A, Kinoshita S, Yoshida T, Takami-Mori F, Takino H, Ito A, Ri M, Ishida T, Komatsu H, Ueda M, Ando Y, Inagaki H, Iida S.
Labial salivary gland biopsy for diagnosing immunoglobulin light chain amyloidosis: a retrospective analysis.
Ann Hematol. 2016 Jan;95(2):279-85. doi: 10.1007/s00277-015-2549-y. Epub 2015 Nov 10. PubMed PMID: 26555284.

稲垣宏：病理検査と病理診断の基礎．第2章　研修で学ぶべき診療・検査手技、B検査の基礎知識　整形外科研修ノート改訂第2版　（斎藤知行、大塚隆信、久保俊一編）診断と治療社、東京、　2016, 82-84

伊藤洋平、稲垣宏：唾液腺腫瘍　第2部　癌の分子病理学　B　臓器別　病理と臨床　臨時増刊号　癌の分子病理学　病理診断から治療標的探索まで　（深山正久、金井弥栄、田中伸哉　編）　34；84-90：2016　文光堂　東京

飯島護丈：医薬品添加物の安全性（非臨床）に係る手引き　―規制情報並びにQ&A―
日本医薬品添加剤協会 安全性委員会2016

飯島護丈：医薬品に係わる添加物と剤型革新における安全性評価2016　日本毒性学会学術年会2016シンポジウム

２０１５年

Kominato S, Kusumoto S, Masuda A, Ishida T, Komatsu H, Mizoshita T, Joh T, Niimi A, Inagaki H, Iida S. [Case Report; An intestinal extranodal NK/T cell lymphoma mimicking Crohn's disease]. Nihon Naika Gakkai Zasshi. 2015 Feb10;104(2):298-301. Japanese. PubMed PMID: 26571710.

Inagaki H, Chan JKC, Jaffe ES, Harris NL, Moller P, Nakamura S. Thymic extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (Chapter 3-6B). WHO Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart, 4th ed. Ed. Travis WD, Brambilla E, Burke AP, Maex A, Nich
olson AG WHO Press Lyon 2015 pp270-271.

Narita T, Ri M, Masaki A, Mori F, Ito A, Kusumoto S, Ishida T, Komatsu H, Iida S.
Lower expression of activating transcription factors 3 and 4 correlates with shorter progression-free survival in multiple myeloma patients receiving bortezomib plus dexamethasone therapy.
Blood Cancer J.2015 Dec 4;5:e373.

Masaki A, Ishida T, Maeda Y, Suzuki S, Ito A, Takino H, Totani H, Yoshida T, Kinoshita S, Ogura H, Narita T, Ri M, Kusumoto S, Inagaki A, Komatsu H, Niimi A, Ueda R, Utsunomiya A, Inagaki H, Iida S.
[Prognostic significance of tryptophan catabolism in adult T-cell leukemia/lymphoma].
Rinsho Ketsueki. 2015 Nov;56(11):2295-304.
doi: 10.11406/rinketsu.56.2295. Japanese. PubMed PMID: 26666715.

Kominato S, Kusumoto S, Masuda A, Ishida T, Komatsu H, Mizoshita T, Joh T, Niimi A, Inagaki H, Iida S.
[Case Report; An intestinal extranodal NK/T cell lymphoma mimicking Crohn's disease].
Nihon Naika Gakkai Zasshi. 2015 Feb 10;104(2):298-301. Japanese.
PubMed PMID: 26571710.

Ishibashi K, Ito Y, Masaki A, Fujii K, Beppu S, Sakakibara T, Takino H, Takase H, Ijichi K, Shimozato K, Inagaki H.
Warthin-like Mucoepidermoid Carcinoma: A Combined Study of Fluorescence In Situ Hybridization and Whole-slide Imaging.
Am J Surg Pathol. 2015 Nov;39(11):1479-87.
doi: 10.1097/PAS.0000000000000507. PubMed PMID: 26457352.

Masaki A, Ishida T, Maeda Y, Suzuki S, Ito A, Takino H, Ogura H, Totani H, Yoshida T, Kinoshita S, Narita T, Ri M, Kusumoto S, Inagaki A, Komatsu H, Niimi A, Ueda R, Utsunomiya A, Inagaki H, Iida S.
Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/Lymphoma.
Clin Cancer Res. 2015 Jun 15;21(12):2830-9.
doi: 10.1158/1078-0432.CCR-14-2275. Epub 2015 Mar 18. PubMed PMID: 25788494.

Ito Y, Ishibashi K, Masaki A, Fujii K, Fujiyoshi Y, Hattori H, Kawakita D, Matsumoto M, Miyabe S, Shimozato K, Nagao T, Inagaki H.
Mammary analogue secretory carcinoma of salivary glands: a clinicopathologic and molecular study including 2 cases harboring ETV6-X fusion.
Am J Surg Pathol. 2015 May;39(5):602-10.
doi: 10.1097/PAS.0000000000000392. PubMed PMID: 25651470.

Totani H, Kusumoto S, Ishida T, Masuda A, Yoshida T, Ito A, Ri M, Komatsu H, Murakami S, Mizokami M, Ueda R, Niimi A, Inagaki H, Tanaka Y, Iida S.
Reactivation of hepatitis B virus (HBV) infection in adult T-cell leukemia-lymphoma patients with resolved HBV infection following systemic chemotherapy.
Int J Hematol. 2015 Apr;101(4):398-404.
doi: 10.1007/s12185-015-1750-z. Epub 2015 Jan 30. PubMed PMID: 25633779.

Takeuchi M, Kawai T, Suzuki T, Naiki T, Kawai N, Fujiyoshi Y, Inagaki H, Kohri K, Hara M, Shibamoto Y.
MRI for differentiation of renal cell carcinoma with sarcomatoid component from other renal tumor types.
Abdom Imaging. 2015 Jan;40(1):112-9.
doi: 10.1007/s00261-014-0185-y. PubMed PMID: 24965897.

Inagaki H.
[Reactive lymphadenopathy and malignant lymphoma: a practical guide to differential diagnosis].
Rinsho Ketsueki.
2014 Oct;55(10):1989-98. Review. Japanese.
PubMed PMID: 25297764.

Suzuki T, Kusumoto S, Masaki A, Ishida T, Inagaki H, Iida S, Mori F.
CD30-positive primary bone marrow lymphoma mimicking Hodgkin lymphoma. Int J
Hematol. 2015 Feb;101(2):109-11.
doi: 10.1007/s12185-014-1714-8. Epub 2014 Nov 28. PubMed PMID: 25430086.

Prieto-Granada CN, Inagaki H, Mueller J.
Thymic Mucoepidermoid Carcinoma: Report of a Case With CTRC1/3-MALM2 Molecular Studies.
Int J Surg Pathol. 2015 Jun;23(4):277-83.
doi: 10.1177/1066896915576959. Epub 2015 Mar 17. PubMed PMID: 25782731.

稲垣宏、伊地知圭　　第2部、組織型と診断の実際、I、悪性腫瘍（２）粘表皮癌　森永正二郎、高田隆、長尾俊孝　編　文光堂 2015　ｐ23-31

稲垣宏、正木彩子： ４．病理診断のポイント. F. 反応性リンパ性病変とリンパ腫の鑑別のポイント　悪性リンパ腫治療マニュアル　改訂第4版　（飛内賢正、木下朝博、塚崎邦弘　編）　南江堂　東京　2015, 45-50

稲垣宏、正木彩子：肺リンパ腫・リンパ腫様肉芽腫症・膿胸関連リンパ腫　X　節外リンパ腫の臓器別特徴と治療　リンパ腫学　最近の研究動向　（谷脇雅史　編）　日本臨床　増刊号；73：638-644　日本臨床社　大阪　2015　

稲垣宏，石橋 謙一郎　唾液腺癌における腫瘍特異的融合遺伝子：最近の進歩　～ワルチン様粘表皮癌～　日本唾液腺学会誌　2015；56：43-48

稲垣宏、坂本祐真　猫ひっかき病　特集／見逃されやすい頸部リンパ節腫脹の原因疾患　血液内科2015;71:376-379

正木彩子, 石田高司, 前田康弘, 鈴木進, 伊藤 旭, 滝野 寿, 戸谷治仁, 吉田嵩, 木下史緒理, 小椋 啓加, 成田朋子, 李政樹, 楠本茂, 稲垣淳, 小松弘和, 新実彰男, 上田 龍三, 宇都宮 與, 稲垣宏, 飯田真介　成人T細胞白血病/リンパ腫におけるトリプトファン代謝の予後に関する意義　臨床血液　2015；56：2295-2304

２０１４年

Design, synthesis, and biological activity of NCC149 derivatives as histone deacetylase 8-selective inhibitors. Suzuki T, Muto N, Bando M, Itoh Y, Masaki A, Ri M, Ota Y, Nakagawa H, Iida S, Shirahige K, Miyata N. ChemMedChem. 2014 Mar;9(3):657-64. doi: 10.1002/cmdc.201300414. Epub 2014 Jan 8. PMID: 24403121 [PubMed - indexed for MEDLINE] Similar articles

HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation. Narita T, Ishida T, Masaki A, Suzuki S, Ito A, Mori F, Yamada T, Ri M, Kusumoto S, Komatsu H, Miyazaki Y, Takatsuka Y, Utsunomiya A, Niimi A, Iida S, Ueda R. J Immunol. 2014 Feb 1;192(3):940-7. doi: 10.4049/jimmunol.1301952. Epub 2013 Dec 20. PMID: 24363428 [PubMed - indexed for MEDLINE] Free Article Similar articles

Ge Y, Takino H,1 Sato F,1 Yamada S, Masaki A, Fujiyoshi Y, Hattori H, Morita A, Kuo T-t, Inagaki H. Distinctive Immunoglobulin VH Gene Features of Cutaneous Marginal Zone Lymphomas in Asian Cases
Br J Dermatol 2014;170:735-7

Miyabe K, Masaki A, Nakazawa T, Ando T, Hayashi K, Naitoh I, Okumura F, Shimizu S, Kondo H, Yoshida M, Yamashita H, Umemura S, Hori Y, Ge Y, Ohara H, Joh T, Inagaki H Histiocytic sarcoma of the bile duct Internal Medicine 2014;53:707-702

Mori F, Ishida T, Ito A, Sato F, Masaki A, Narita T, Suzuki S, Yamada T, Takino H, Ri M, Kusumoto S, Komatsu H, Hishizawa M, Imada K, Takaori-Kondo A, Niimi A, Ueda R, Inagaki H, Iida S Antitumor effects of bevacizumab in a microenvironment-dependent human adult T-cell leukemia/lymphoma mouse model
European Journal of Haematology 2014;92:219-28

Ogura M, Ishida T, Hatake K, Taniwaki M, Ando K, Tobinai K, Fujimoto K, Yamamoto K, Miyamoto T, Uike N, Tanimoto M, Tsukasaki K, Ishizawa K, Suzumiya J, Inagaki H, Tamura K, Akinaga S, Tomonaga M, Ueda R.
Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-CCR4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma
J Clin Oncol 2014;32:1157-63

Xia H, Yamada S, Aoyama M, Sato F, Masaki A, Ge Y, Ri M, Ishida T, Ueda R, Utsunomiya A, Asai K, Inagaki H. Prognostic impact of miR-145 down-regulation in adult T-cell leukemia/ lymphoma
Human Pathology 2014;45(6):1192-8.

Narita T, Ishida T, Masaki A, Suzuki S, Ito A, Mori F, Yamada T, Ri M, Kusumoto S, Komatsu H, Miyazaki Y, Takatsuka Y, Utsunomiya A, Niimi A, Iida S, Ueda R.
HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation. J Immunol. 2014 Feb 1;192(3):940-7.

Suzuki T, Muto N, Bando M, Itoh Y, Masaki A, Ri M, Ota Y, Nakagawa H, Iida S, Shirahige K, Miyata N.
Design, synthesis, and biological activity of NCC149 derivatives as histone deacetylase 8-selective inhibitors. ChemMedChem.
2014 Mar;9(3):657-64.

２０１３年

Ishida T, Ito A, Sato F, Kusumoto S, Iida S, Inagaki H, Morita A, Akinaga S, Ueda R. Stevens-Johnson Syndrome associated with mogamulizumab treatment of Adult T-cell leukemia/lymphoma
Cancer Sci 2013 May;104(5):647-50.
10.1111/cas.12116

Takino H, Li C, Yamada S, Sato F, Masaki A, Fujiyoshi Y, Hattori H, Inagaki H. Thymic Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue: A Gene Methylation Study Leuk Lymphoma 2013;54:1742-6

Kato H, Saito C, Ito E, Furuhashi T, Nishida E, Ishida T, Ueda R, Inagaki H, Morita A. Bath-PUVA therapy decreases infiltrating CCR4-expressing tumor cells and regulatory T cells in patients with mycosis fungoides
Clinical Lymphoma Myeloma and Leukemia, 2013 Jan 15. doi:pii: S2152-2650(12)00288-1.

Noda H, Okumura Y, Nakayama T, Miyabe S, Fujiyoshi Y, Hattori H, Shimozato K, Inagaki H. Clinicopathological Significance of MAML2 Gene Split in Mucoepidermoid Carcinoma Cancer Sci 2013;104:85-92
10.1111/cas.12039

Masaki A, Ishida T, Suzuki S, Ito A, Mori F, Sato F, Narita T, Yamada T, Ri M, Kusumoto S, Komatsu H, Tanaka Y, Niimi A, Inagaki H, Iida S, Ueda R
Autologous Tax-specific CTL therapy in a primary ATL cell-bearing
NOD/Shi-scid, IL-2Rγnull mouse model. J Immunol 2013;191:135-44

Suzuki S, Watanabe S, Kato H, Inagaki H, Hattori H, Morita A. A case of Scutaneous malignant fibrous histiocytoma with multiple organ metastases. Kaohsiung J Med Sci. 2013 Feb;29(2):111-5. doi: 10.1016/j.kjms.2012.08.019. Epub 2012 Oct 13. PubMed PMID: 23347814.

Shibata T, Matsuo Y, Shamoto T, Hirokawa T, Tsuboi K, Takahashi H, Ishiguro H, Kimura M, Takeyama H, Inagaki H.
Girdin, a regulator of cell motility, is a potential prognostic marker for esophageal squamous cell carcinoma. Oncol Rep. 2013 Jun;29(6):2127-32. doi: 10.3892/or.2013.2406. Epub 2013 Apr 12.

Takeuchi M, Urano M, Hara M, Fujiyoshi Y, Inagaki H, Shibamoto U. Characteristic MR Imaging Findings of Sarcomatoid Renal Cell Carcinoma Dedifferentiated from Clear Cell Renal Carcinoma: Radiological-Pathological Correlation Clinical Imaging 2013;37:908-912

Inagaki A, Tajima E, Uranishi M, Totani H, Asao Y, Ogura H, Masaki A, Yoshida T, Mori F, Ito A, Yano H, Ri M, Kayukawa S, Kataoka T, Kusumoto S, Ishida, T, Hayami Y, Hanamura I, Komatsu H, Inagaki H, Matsuda Y, Ueda R, Iida S
Global real-time quantitative reverse transcription-polymerase chain reaction detecting protooncogenes associated with 14q32 chromosomal translocation as a valuable marker for predicting survival in multiple myeloma. Leukemia Research 2013;37:1648-55

Sato F, Ishida T, Ito A, Mori F, Masaki A, Takino H, Narita T, Ri M, Kusumoto S, Suzuki S, Komatsu H, Niimi A, Ueda R, Inagaki H, Iida S. Angioimmunoblastic T-cell lymphoma mice model. Leuk Res. 2013 Jan;37(1):21-7. doi:pii: S0145-2126(12)00382-7.

２０１２年

２０１１年

---

---